With median follow-up of 44 months , 3-year EFS for all 716 randomly assigned patients was 76 % ( 95 % CI , 72 % to 79 % ) ; 174 EFS events were reported ( MAP , n = 93 ; MAP plus IFN -- 2b , n = 81 ) .